시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 당뇨병 펜 시장 보고서(2025년)
Diabetes Pen Global Market Report 2025
상품코드 : 1824639
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,664,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,632,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,600,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

당뇨병 펜 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.3%를 나타내 395억 9,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 인구와 도시화 증가, 수질 오염과 오염 증가, 효율적인 자원 관리의 필요성, 정확하고 실시간 물 데이터의 필요성, 물 재사용 및 재활용 수요 증가로 인한 것입니다. 예측 기간 중 주요 동향으로는 AI와 ml 등의 디지털 기술의 진보, iot와 클라우드 컴퓨팅의 채용 확대, 물 관련 과제에 대한 대응이 급무인 것, 물 인프라에 대한 투자가 증가하고 있는 것, 유틸리티 부문의 디지털화가 가속되고 있는 것 등을 들 수 있습니다.

향후 5년간의 성장률 6.3%라고 하는 예측은 이 시장의 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 덴마크와 중국에서 공급되는 연결형 인슐린 펜과 일회용 카트리지의 비용을 상승시키고, 정밀 투여에 대한 접근을 낮추고, 당뇨병 관리 비용을 증가시킴으로써 미국 시장을 저해할 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

세계적인 당뇨병 유병률 증가가 향후 수년간 당뇨병 펜 시장 확대의 원동력이 될 것으로 예측됩니다. 당뇨병은 높은 혈당(고혈당)를 특징으로 하는 만성 대사질환군을 포함합니다. 당뇨병 펜은 보다 정확한 투여, 어드히어런스 향상, 저혈당 위험 감소를 실현하는 인슐린 전달 장치입니다. 이 펜은 또한 주사 부위의 통증이 적고 인슐린이 필요한 당뇨병 환자에게 선호되는 선택입니다. 예를 들어, 미국 전문기관인 미국 당뇨병학회는 2023년 5월, 2021년 20-79세 성인에 있어서 내당능 이상(IGT)의 연령 조정 유병률은 9.1%(4억6,400만명)였다고 보고했습니다. 이 수치는 2045년 10.0%(6억 3,800만 명)로 상승할 것으로 예측됩니다. 그 결과, 세계적인 당뇨병 이환율 증가가 당뇨병 펜 시장 성장에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

A diabetes pen is a medical device specifically designed for administering insulin to individuals with diabetes, serving as an alternative to traditional insulin delivery methods such as vial and syringe. It offers a convenient and user-friendly option, allowing individuals with diabetes to self-administer insulin discreetly and in a portable manner.

The primary products associated with diabetes pens include insulin pens and pen needles. Insulin pens are widely used as convenient tools for managing blood sugar levels in people with diabetes, offering simplicity in measuring and administering insulin. They come in both reusable and disposable options for insulin, glucagon-such as peptide-1, growth hormones, fertility, and osteoporosis treatment, and are distributed through various channels such as retail pharmacies, online medical stores, and diabetes clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The diabetes pen market research report is one of a series of new reports from The Business Research Company that provides diabetes pen market statistics, including diabetes pen industry global market size, regional shares, competitors with a diabetes pen market share, detailed diabetes pen market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes pen industry. This diabetes pen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diabetes pen market size has grown strongly in recent years. It will grow from $29.24 billion in 2024 to $31.04 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to managing scarce water resources, ageing water infrastructure, escalating call for quality water services, rising demand for smart water solutions, improving efficiency in operation.

The diabetes pen market size is expected to see strong growth in the next few years. It will grow to $39.59 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to growing population and urbanization, increasing water pollution and contamination, need for efficient resource management, need for accurate and real-time water data, increasing demand for water reuse and recycling. Major trends in the forecast period include advancements in digital technologies such as ai and ml, increasing adoption of iot and cloud computing, pressing need to address water-related challenges, increasing investment in water infrastructure, escalating digitization of the utility sector.

The forecast of 6.3% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of connected insulin pens and disposable cartridges sourced from Denmark and China, thereby reducing accessibility for precision dosing and elevating diabetes management costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of diabetes globally is expected to drive the expansion of the diabetes pen market in the coming years. Diabetes encompasses a group of chronic metabolic disorders marked by high blood sugar levels (hyperglycemia). Diabetes pens are insulin delivery devices that provide more precise dosing, improved adherence, and reduced risk of hypoglycemia. These pens are also associated with less pain at the injection site, making them a preferred choice for individuals with diabetes who need insulin. For example, the American Diabetes Association, a US-based professional organization, reported in May 2023 that, in 2021, the age-adjusted prevalence of Impaired Glucose Tolerance (IGT) among adults aged 20-79 was 9.1% (464 million). This figure is projected to rise to 10.0% (638 million) by 2045. Consequently, the increasing global incidence of diabetes is fueling the growth of the diabetes pen market.

Key players in the diabetes pen market are focusing on developing innovative products, such as virtually painless injections, to improve the user experience. A virtually painless injection is a method specifically designed to reduce discomfort during medication administration, enhancing patient comfort and making insulin management easier for individuals without fear or pain. For example, in May 2022, Roche AG, a Switzerland-based medical equipment company, introduced ACCU-FINE pen needles. These needles are designed to improve the insulin delivery process by providing a virtually painless injection, thereby enhancing compliance and health outcomes for people with diabetes.

In September 2023, Abbott Laboratories, a US-based healthcare company, acquired Bigfoot Biomedical Inc. This strategic acquisition is poised to bolster Abbott's presence in the diabetes market by expanding its product offerings and gaining access to Bigfoot Biomedical's customer base. The acquisition aims to improve diabetic care and patient outcomes through the integration of knowledge and technologies. Bigfoot Biomedical Inc., based in the US, specializes in diabetes management systems, including insulin pens and smart pen caps.

Major companies operating in the diabetes pen market report are F. Hoffman La Roche AG, Sanofi S.A., Astra Zeneca PLC, Fujitsu Limited, Eli Lilly and Company, Bayer Cropscience Ltd., Ericsson, Novo Nordisk A/S, BD, Bristol-Myers Squibb, Teruma Medical Corporation, Smiths Group plc., Greinier Bio One International GmBH (U.S.), YPSOMED, Owen Mumford Ltd., WOCKHARDT, Nipro Europe Group Companies, Biocon, Copernicus, Mannkind Corporation, Jiangsu Delfu medical device Co., HTL-STREFA Inc., DeepSig, Injex UK Ltd.

North America was the largest region in the diabetes pen market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes pen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diabetes pen market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The diabetes pen market includes revenues earned by entities by insulin delivery, cartridge or prefilled, and dosing mechanism. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes pen market also includes sales of fixed-dose pens, multi-dose pens, and adjustable-dose pens for providing select the desired amount of insulin to be injected services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetes Pen Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetes pen market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for diabetes pen ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetes pen market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Diabetes Pen Market Characteristics

3. Diabetes Pen Market Trends And Strategies

4. Diabetes Pen Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Diabetes Pen Growth Analysis And Strategic Analysis Framework

6. Diabetes Pen Market Segmentation

7. Diabetes Pen Market Regional And Country Analysis

8. Asia-Pacific Diabetes Pen Market

9. China Diabetes Pen Market

10. India Diabetes Pen Market

11. Japan Diabetes Pen Market

12. Australia Diabetes Pen Market

13. Indonesia Diabetes Pen Market

14. South Korea Diabetes Pen Market

15. Western Europe Diabetes Pen Market

16. UK Diabetes Pen Market

17. Germany Diabetes Pen Market

18. France Diabetes Pen Market

19. Italy Diabetes Pen Market

20. Spain Diabetes Pen Market

21. Eastern Europe Diabetes Pen Market

22. Russia Diabetes Pen Market

23. North America Diabetes Pen Market

24. USA Diabetes Pen Market

25. Canada Diabetes Pen Market

26. South America Diabetes Pen Market

27. Brazil Diabetes Pen Market

28. Middle East Diabetes Pen Market

29. Africa Diabetes Pen Market

30. Diabetes Pen Market Competitive Landscape And Company Profiles

31. Diabetes Pen Market Other Major And Innovative Companies

32. Global Diabetes Pen Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetes Pen Market

34. Recent Developments In The Diabetes Pen Market

35. Diabetes Pen Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기